Brain natriuretic peptide induces CD8+ T cell death via a caspase 3 associated pathway - Implications following heart transplantation

Transplant Immunology

Volumn 26, Issue 2-3, 2012, Pages 119-122

  Shaw, Steven M ^a   Critchley, William R ^a   Puchalka, Christopher M ^a   Williams, Simon G ^a   Yonan, Nizar ^a   Fildes, James E ^a,b  

^a WYTHENSHAWE HOSPITAL   (United Kingdom)

^b UNIVERSITY OF MANCHESTER   (United Kingdom)

Author keywords

BNP; Cardiac transplantation; Cytokines; Immune system; Immunomodulation

Indexed keywords

BRAIN NATRIURETIC PEPTIDE; CASPASE 3; CHEMOKINE; CYCLOSPORIN; CYTOKINE; GROWTH FACTOR; INTERLEUKIN 13; INTERLEUKIN 1ALPHA; INTERLEUKIN 4; INTERLEUKIN 5; INTERLEUKIN 6; TACROLIMUS; TUMOR NECROSIS FACTOR ALPHA;

ADULT; AGED; ARTICLE; CARDIAC GRAFT REJECTION; CD8+ T LYMPHOCYTE; CELL COUNT; CELL DEATH; CELL ISOLATION; CLINICAL ARTICLE; COCULTURE; CYTOKINE PRODUCTION; FEMALE; FLOW CYTOMETRY; GRAFT RECIPIENT; HEART TRANSPLANTATION; HUMAN; IMMUNOPHENOTYPING; MALE; MITOCHONDRIAL MEMBRANE; PERIPHERAL BLOOD MONONUCLEAR CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN PROTEIN INTERACTION; PROTEIN SYNTHESIS;

ADULT; AGED; APOPTOSIS; CASPASE 3; CD8-POSITIVE T-LYMPHOCYTES; CELLS, CULTURED; CYTOKINES; FEMALE; GRAFT REJECTION; HEART TRANSPLANTATION; HUMANS; MALE; MIDDLE AGED; MITOCHONDRIAL MEMBRANES; NATRIURETIC PEPTIDE, BRAIN; TIME FACTORS; TRANSPLANTATION, HOMOLOGOUS;

EID: 84856534863     PISSN: 09663274     EISSN: 18785492     Source Type: Journal    
DOI: 10.1016/j.trim.2011.11.007     Document Type: Article

References (27)

1. Battaglia M., Pewsner D., Juni P., Egger M., Bucher H.C., Bachmann L.M. Accuracy of B-type natriuretic peptide tests to exclude congestive heart failure: systematic review of test accuracy studies. Arch Intern Med 2006, 166:1073-1080.
2. Kinnunen P., Vuolteenaho O., Ruskoaho H. Mechanisms of atrial and brain natriuretic peptide release from rat ventricular myocardium: effect of stretching. Endocrinology 1993, 132:1961-1970.
3. Vanderheyden M., Bartunek J., Goethals M. Brain and other natriuretic peptides: molecular aspects. Eur J Heart Fail 2004, 6:261-268.
4. Talha S., Di Marco P., Doutreleau S., Rouyer O., Piquard F., Geny B. Does circulating BNP normalize after heart transplantation in patients with normal hemodynamic and right and left heart functions?. Clin Transplant 2008, 22:542-548.
5. Masters R.G., Davies R.A., Veinot J.P., Hendry P.J., Smith S.J., de Bold A.J. Discoordinate modulation of natriuretic peptides during acute cardiac allograft rejection in humans. Circulation 1999, 100:287-291.
6. Hervas I., Almenar L., Perez-Pastor J.L., Chirivella M., Osa A., Martinez-Dolz L., et al. Radioimmunometric assay of B-type natriuretic peptide (BNP) in heart transplantation: correlation between BNP determinations and biopsy grading of rejection. Nucl Med Commun 2003, 24:925-931.
7. Hervas I., Arnau M.A., Almenar L., Perez-Pastor J.L., Chirivella M., Osca J., et al. Ventricular natriuretic peptide (BNP) in heart transplantation: BNP correlation with endomyocardial biopsy, laboratory and hemodynamic measures. Lab Invest 2004, 84:138-145.
8. Hammerer-Lercher A., Mair J., Antretter H., Ruttmann E., Poelzl G., Laufer G., et al. B-type natriuretic peptide as a marker of allograft rejection after heart transplantation. J Heart Lung Transplant 2005, 24:1444.
9. Wu A.H., Johnson M.L., Aaronson K.D., Gordon D., Dyke D.B., Koelling T.M. Brain natriuretic peptide predicts serious cardiac allograft rejection independent of hemodynamic measurements. J Heart Lung Transplant 2005, 24:52-57.
10. Mondillo S., Maccherini M., Galderisi M. Usefulness and limitations of transthoracic echocardiography in heart transplantation recipients. Cardiovasc Ultrasound 2008, 6:2.
11. Baggish A.L., van Kimmenade R.R., Januzzi J.L. The differential diagnosis of an elevated amino-terminal pro-B-type natriuretic peptide level. Am J Cardiol 2008, 101:43-48.
12. Shaw S.M., Fildes J., Yonan N., Williams S.G. Does brain natriuretic peptide interact with the immune system after cardiac transplantation?. Transplantation 2007, 84:1377-1381.
13. Vollmar A.M., Schulz R. Expression and differential regulation of natriuretic peptides in mouse macrophages. J Clin Invest 1995, 95:2442-2450.
14. Bruggink A.H., de Jonge N., van Oosterhout M.F., Van Wichen D.F., de Koning E., Lahpor J.R., et al. Brain natriuretic peptide is produced both by cardiomyocytes and cells infiltrating the heart in patients with severe heart failure supported by a left ventricular assist device. J Heart Lung Transplant 2006, 25:174-180.
15. Shaw S.M., Fildes J.E., Puchalka C.M., Basith M., Yonan N., Williams S.G. BNP directly immunoregulates the innate immune system of cardiac transplant recipients in vitro. Transpl Immunol 2009, 20:199-202.
16. Taylor D.O., Edwards L.B., Boucek M.M., Trulock E.P., Aurora P., Christie J., et al. Registry of the International Society for Heart and Lung Transplantation: twenty-fourth official adult heart transplant report-2007. J Heart Lung Transplant 2007, 26:769-781.
17. Rogers N.J., Lechler R.I. Allorecognition. Am J Transplant 2001, 1:97-102.
18. Game D.S., Lechler R.I. Pathways of allorecognition: implications for transplantation tolerance. Transpl Immunol 2002, 10:101-108.
19. Evans M.J., Livesey J.H., Ellis M.J., Yandle T.G. Effect of anticoagulants and storage temperatures on stability of plasma and serum hormones. Clin Biochem 2001, 34:107-112.
20. Betts M.R., Brenchley J.M., Price D.A., De Rosa S.C., Douek D.C., Roederer M., et al. Sensitive and viable identification of antigen-specific CD8+ T cells by a flow cytometric assay for degranulation. J Immunol Methods 2003, 281:65-78.
21. De Bold M.L., Etchepare A., Martinuk A., de Bold A.J. Cardiac hormones ANF and BNP modulate proliferation in the unidirectional mixed lymphocyte reaction. J Heart Lung Transplant 2010, 29:323-326.
22. Ogawa T., Veinot J.P., de Bold ML Kuroski, Georgalis T., de Bold A.J. Angiotensin II receptor antagonism reverts the selective cardiac BNP upregulation and secretion observed in myocarditis. Am J Physiol Heart Circ Physiol 2008, 294:H2596-H2603.
23. Morita R., Ukyo N., Furuya M., Uchiyama T., Hori T. Atrial natriuretic peptide polarizes human dendritic cells toward a Th2-promoting phenotype through its receptor guanylyl cyclase-coupled receptor A. J Immunol 2003, 170:5869-5875.
24. Baldini P.M., De Vito P., Martino A., Fraziano M., Grimaldi C., Luly P., et al. Differential sensitivity of human monocytes and macrophages to ANP: a role of intracellular pH on reactive oxygen species production through the phospholipase involvement. J Leukoc Biol 2003, 73:502-510.
25. Aktas E., Kucuksezer U.C., Bilgic S., Erten G., Deniz G. Relationship between CD107a expression and cytotoxic activity. Cell Immunol 2009, 254:149-154.
26. Conlon K., Lloyd A., Chattopadhyay U., Lukacs N., Kunkel S., Schall T., et al. CD8+ and CD45RA+ human peripheral blood lymphocytes are potent sources of macrophage inflammatory protein 1 alpha, interleukin-8 and RANTES. Eur J Immunol 1995, 25:751-756.
27. Colucci W.S., Elkayam U., Horton D.P., Abraham W.T., Bourge R.C., Johnson A.D., et al. Intravenous nesiritide, a natriuretic peptide, in the treatment of decompensated congestive heart failure. Nesiritide Study Group. N Engl J Med 2000, 343:246-253.